High MAPK10 expression may thus act in an anti-tumor manner by promoting immune surveillance in the TME, whereas reduced MAPK10 expression in HCC might facilitate tumor growth due to reduced immune milieu in the TME promoting the evasion of immune surveillance by cancer cells (Figure 4C), as indicated by our transcriptome analysis. This evidence concerns the gene MAPK10 and neoplasm.